EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells
Application of the platinum-based chemotherapy for colorectal cancer is restricted due to its severe cytotoxic effects. In this study we used synergistic strategies by combining (−)-Epigallocatechin gallate (EGCG) with cisplatin or oxaliplatin to minimize the ill effects of platinum-based therapy. M...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-05-01
|
| Series: | Journal of Pharmacological Sciences |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861315000766 |
| _version_ | 1819169366766256128 |
|---|---|
| author | Fen Hu Fei Wei Yulei Wang Bibo Wu Yuan Fang Bin Xiong |
| author_facet | Fen Hu Fei Wei Yulei Wang Bibo Wu Yuan Fang Bin Xiong |
| author_sort | Fen Hu |
| collection | DOAJ |
| description | Application of the platinum-based chemotherapy for colorectal cancer is restricted due to its severe cytotoxic effects. In this study we used synergistic strategies by combining (−)-Epigallocatechin gallate (EGCG) with cisplatin or oxaliplatin to minimize the ill effects of platinum-based therapy. MTS assay was used to examine the effect of EGCG, cisplatin and oxaliplatin on the proliferation of human colorectal cancer DLD-1 and HT-29 cells. Autophagic process was evaluated by detection of LC3-II protein, autophagosome formation, and quantification of Acidic Vesicular. Treatment of DLD-1 and HT-29 cells with EGCG plus cisplatin or oxaliplatin showed a synergistic effect on inhibition of cell proliferation and induction of cell death. EGCG enhanced the effect of cisplatin and oxaliplatin-induced autophagy in DLD-1 and HT-29 cells, as characterized by the accumulation of LC3-II protein, the increase of acidic vesicular organelles (AVOs), and the formation of autophagosome. In addition, transfection of DLD-1 and HT-29 cells with siRNA against ATG genes reduced EGCG synergistic effect. Our findings suggest that combining EGCG with cisplatin or oxaliplatin could potentiate the cytotoxicity of cisplatin and oxaliplatin in colorectal cancer cells through autophagy related pathway. |
| first_indexed | 2024-12-22T19:18:22Z |
| format | Article |
| id | doaj.art-6c0d79b038814e6d8544f4d20f012d43 |
| institution | Directory Open Access Journal |
| issn | 1347-8613 |
| language | English |
| last_indexed | 2024-12-22T19:18:22Z |
| publishDate | 2015-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Pharmacological Sciences |
| spelling | doaj.art-6c0d79b038814e6d8544f4d20f012d432022-12-21T18:15:27ZengElsevierJournal of Pharmacological Sciences1347-86132015-05-011281273410.1016/j.jphs.2015.04.003EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cellsFen Hu0Fei Wei1Yulei Wang2Bibo Wu3Yuan Fang4Bin Xiong5Department of Oncology, Zhongnan Hospital of Wuhan University, Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan 430071, ChinaState Key Laboratory of Virology, National Laboratory of Antiviral and Tumor of Traditional Chinese Medicine, Institute of Medical Virology, Research Center of Food and Drug Evaluation, School of Medicine, Wuhan University, Wuhan 430071, ChinaDepartment of Oncology, Zhongnan Hospital of Wuhan University, Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan 430071, ChinaDepartment of Oncology, Zhongnan Hospital of Wuhan University, Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan 430071, ChinaDepartment of Oncology, Zhongnan Hospital of Wuhan University, Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan 430071, ChinaDepartment of Oncology, Zhongnan Hospital of Wuhan University, Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan 430071, ChinaApplication of the platinum-based chemotherapy for colorectal cancer is restricted due to its severe cytotoxic effects. In this study we used synergistic strategies by combining (−)-Epigallocatechin gallate (EGCG) with cisplatin or oxaliplatin to minimize the ill effects of platinum-based therapy. MTS assay was used to examine the effect of EGCG, cisplatin and oxaliplatin on the proliferation of human colorectal cancer DLD-1 and HT-29 cells. Autophagic process was evaluated by detection of LC3-II protein, autophagosome formation, and quantification of Acidic Vesicular. Treatment of DLD-1 and HT-29 cells with EGCG plus cisplatin or oxaliplatin showed a synergistic effect on inhibition of cell proliferation and induction of cell death. EGCG enhanced the effect of cisplatin and oxaliplatin-induced autophagy in DLD-1 and HT-29 cells, as characterized by the accumulation of LC3-II protein, the increase of acidic vesicular organelles (AVOs), and the formation of autophagosome. In addition, transfection of DLD-1 and HT-29 cells with siRNA against ATG genes reduced EGCG synergistic effect. Our findings suggest that combining EGCG with cisplatin or oxaliplatin could potentiate the cytotoxicity of cisplatin and oxaliplatin in colorectal cancer cells through autophagy related pathway.http://www.sciencedirect.com/science/article/pii/S1347861315000766EGCGCisplatinOxaliplatinAutophagic death |
| spellingShingle | Fen Hu Fei Wei Yulei Wang Bibo Wu Yuan Fang Bin Xiong EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells Journal of Pharmacological Sciences EGCG Cisplatin Oxaliplatin Autophagic death |
| title | EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells |
| title_full | EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells |
| title_fullStr | EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells |
| title_full_unstemmed | EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells |
| title_short | EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells |
| title_sort | egcg synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells |
| topic | EGCG Cisplatin Oxaliplatin Autophagic death |
| url | http://www.sciencedirect.com/science/article/pii/S1347861315000766 |
| work_keys_str_mv | AT fenhu egcgsynergizesthetherapeuticeffectofcisplatinandoxaliplatinthroughautophagicpathwayinhumancolorectalcancercells AT feiwei egcgsynergizesthetherapeuticeffectofcisplatinandoxaliplatinthroughautophagicpathwayinhumancolorectalcancercells AT yuleiwang egcgsynergizesthetherapeuticeffectofcisplatinandoxaliplatinthroughautophagicpathwayinhumancolorectalcancercells AT bibowu egcgsynergizesthetherapeuticeffectofcisplatinandoxaliplatinthroughautophagicpathwayinhumancolorectalcancercells AT yuanfang egcgsynergizesthetherapeuticeffectofcisplatinandoxaliplatinthroughautophagicpathwayinhumancolorectalcancercells AT binxiong egcgsynergizesthetherapeuticeffectofcisplatinandoxaliplatinthroughautophagicpathwayinhumancolorectalcancercells |